Correlation Between Sonnet Biotherapeutics and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Inozyme Pharma, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Inozyme Pharma.
Diversification Opportunities for Sonnet Biotherapeutics and Inozyme Pharma
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Sonnet and Inozyme is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Inozyme Pharma go up and down completely randomly.
Pair Corralation between Sonnet Biotherapeutics and Inozyme Pharma
Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to generate 1.52 times more return on investment than Inozyme Pharma. However, Sonnet Biotherapeutics is 1.52 times more volatile than Inozyme Pharma. It trades about 0.05 of its potential returns per unit of risk. Inozyme Pharma is currently generating about 0.03 per unit of risk. If you would invest 154.00 in Sonnet Biotherapeutics Holdings on November 18, 2024 and sell it today you would earn a total of 5.00 from holding Sonnet Biotherapeutics Holdings or generate 3.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sonnet Biotherapeutics Holding vs. Inozyme Pharma
Performance |
| Timeline |
| Sonnet Biotherapeutics |
| Inozyme Pharma |
Sonnet Biotherapeutics and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sonnet Biotherapeutics and Inozyme Pharma
The main advantage of trading using opposite Sonnet Biotherapeutics and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| Sonnet Biotherapeutics vs. ZyVersa Therapeutics | Sonnet Biotherapeutics vs. Allarity Therapeutics | Sonnet Biotherapeutics vs. Immix Biopharma | Sonnet Biotherapeutics vs. Cns Pharmaceuticals |
| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |